VistaGen Therapeutics
VTGN
VTGN
85 hedge funds and large institutions have $4.75M invested in VistaGen Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
48% less capital invested
Capital invested by funds: $9.13M → $4.75M (-$4.39M)
Holders
85
Holding in Top 10
–
Calls
$4K
Puts
$2K
Top Buyers
| 1 | +$59.1K | |
| 2 | +$54.7K | |
| 3 | +$25.4K | |
| 4 |
GWSG
GPS Wealth Strategies Group
Centennial,
Colorado
|
+$24.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$18.3K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$384K | |
| 3 | -$127K | |
| 4 |
Millennium Management
New York
|
-$76.5K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$50K |